H-MESO-1
Brand : CLS Cell Lines Service
H-MESO-1 Cells
General information
Description | H-MESO-1 cells are a human mesothelioma cell line derived from a patient with malignant pleural mesothelioma, a type of cancer that develops from the cells lining the lungs' or abdomen's protective lining. This cell line is extensively used in oncological research to study the biology, pathogenesis, and therapeutic strategies for mesothelioma. H-MESO-1 cells retain several characteristics of mesothelial cells, making them a relevant model for investigating mesothelioma. They exhibit epithelioid morphology, which is one of the common histological types of mesothelioma. These cells are particularly useful for exploring the molecular pathways involved in mesothelioma development, including cell cycle regulation, apoptosis resistance, and the role of asbestos and other environmental factors in inducing mesothelioma. In research, H-MESO-1 cells have been employed to study the interaction between mesothelioma cells and the immune system, especially considering the impact of immune checkpoint molecules and the tumor microenvironment on tumor growth and immune evasion. This cell line is also valuable for testing the efficacy of new drugs and novel immunotherapeutic approaches aimed at targeting specific pathways implicated in mesothelioma progression. Moreover, H-MESO-1 cells are used to investigate the genetic and epigenetic alterations characteristic of mesothelioma, providing insights into potential biomarkers for early diagnosis and targets for therapeutic intervention. The cell line's responsiveness to chemotherapeutic agents and its ability to form tumors in xenograft models make it a crucial tool in developing and validating new treatment modalities for mesothelioma. |
---|---|
Organism | Human |
Tissue | Lung |
Disease | Pleural Mesothelioma |
Synonyms | H-Meso-1, HMESO-1, HMeso-1, HMeso1, HMESO1, H-Meso, HMESO, Hmeso, Hmeso |
Characteristics
Age | 35 years |
---|---|
Gender | Male |
Ethnicity | Caucasian |
Morphology | Epithelial-like |
Growth properties | Adherent |
Identifiers / Biosafety / Citation
Citation | H-MESO-1 (Cytion catalog number 300186) |
---|---|
Biosafety level | 1 |
Expression / Mutation
Tumorigenic | Yes, in nude mice |
---|
Handling
Culture Medium | RPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
---|---|
Medium supplements | Supplement the medium with 10% FBS |
Passaging solution | Accutase |
Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
Split ratio | A ratio of 1:2 to 1:4 is recommended |
Seeding density | 1 x 10^4 cells/cm^2 |
Fluid renewal | Every 5 to 7 days |
Freezing recovery | After thawing, plate the cells at 5 x 10^4 cells/cm^2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours. |
Freeze medium | CM-1 (Cytion catalog number 800100) or CM-ACF (Cytion catalog number 806100) |
Handling of cryopreserved cultures |
|
Quality control / Genetic profile / HLA
Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
---|---|
STR profile | Amelogenin: x,y CSF1PO: 11,12 D13S317: 11 D16S539: 12 D5S818: 10,12 D7S820: 12 TH01: 6,9.3 TPOX: 8 vWA: 17 D3S1358: 14 D21S11: 30,33.2 D18S51: 14,20 Penta E: 7,11 Penta D: 11,13 D8S1179: 10 FGA: 23 |
HLA alleles | A*: 02:01:01 B*: 13:02:01, 44:02:01 C*: 06:02:01, 07:04:01 DRB1*: 07:01:01, 13:01:01 DQA1*: 01:03:01, 02:01:01 DQB1*: 02:02:01, 06:03:01 DPB1*: 03:01, 20:01:01 E: 01:01, 01:03 |